NCT04547348View on ClinicalTrials.gov

The DENOCHARCOT Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions
Charcot FootDiabetes Mellitus
Interventions
DRUG

Denosumab Injection

Injections made subcutaneously per standard description

Trial Locations (8)

2400

RECRUITING

Bispebjerg Hospital, Copenhagen NV

Unknown

RECRUITING

Steno Diabetes Center North, Aalborg

RECRUITING

Steno Diabetes Center Aarhus, Aarhus

RECRUITING

Steno Diabetes Center Copenhagen, Gentofte Municipality

RECRUITING

Nordsjællands Hospital, Hillerød

RECRUITING

Hvidovre hospital, Hvidovre

RECRUITING

Zealand University Hospital, Køge

RECRUITING

Steno Diabetes Center Odense, Odense

All Listed Sponsors
lead

Ole Lander Svendsen

OTHER